FAVOR III China: quantitative flow ratio-guided coronary intervention in practice.
FAVOR III China: quantitative flow ratio-guided coronary intervention in practice.
复制标题
FAVOR III 中国:定量血流比引导冠状动脉介入治疗的实践。
DOI:
10.1093/cvr/cvac109
复制
发表时间:
2022
影响因子:
10.8
通讯作者:
Ang D
中科院分区:
文献类型:
--
作者:
Ang D
Pressure wire-based physiological assessment with fractional flow reserve (FFR) and the instantaneous wave-free ratio (iFR) more accurately identifies flow-limiting lesions than angiographic assessment alone. As such, they are recommended by international guidelines to aid decisions on revascularization. 1, 2 Incorporation of FFR data during lesion assessment alters revascularization decisions in the cardiac catheterization laboratory. 3 Importantly, it may lead to improved prognosis in chronic 4 and acute coronary syndromes. 5However, the adoption of invasive physiological measurements remains limited in clinical practice. This is partially driven by the need for coronary instrumentation, increased procedural time and cost. As such, there is increasing interest in non-invasive physiological measurements as an adjunct to angiography. In general, these techniques are calculated by computational modelling and flow dynamics based on the laws of Bernoulli and/or Poiseuille. 6 Data can be acquired from either CT 7 or invasive coronary angiography. 8 Studies so far have shown reliable correlation between non-invasive indices and invasive FFR. 6 In the FAST II study, Masdjedi et al. 8 demonstrated a 81% sensitivity and 95% specificity of quantitative coronary angiography-based vessel FFR in identifying an invasive FFR≤ 0.80. Akin to many other non-invasive indices, the upload and analysis of angiographic data using a central core-lab have thus far limited its real-time utility in clinical practice. Morris et al. 6 provided a summary of recent angiographybased physiological assessment techniques, along with their potential pitfalls. Within this context, Xu et al. 9 provide new data from the FAVOR III China trial, which sought to determine whether the peri-procedural use of quantitative flow ratio (QFR) to guide lesion selection for percutaneous coronary intervention (PCI) might improve clinical outcomes, compared with angiography-guidance alone. This investigator-initiated, multicentre, blinded, randomized, sham-controlled trial enrolled 3847 patients from 26 centres in China between 25/12/2018 and 19/01/2020. Patients aged≥ 18 years with chronic coronary syndromes or myocardial infarction≥ 72 h before screening, who had≥ 1 lesion with diameter stenosis 50–90% in a coronary artery≥ 2.5 mm reference diameter were eligible. The main exclusion criteria were moderate or severe chronic kidney disease (defined as creatinine> 150 μmol/L or estimated glomerular filtration rate< 45 mL/kg/173 m2), severe vessel tortuosity, vessel overlap, or suboptimal angiographic images for QFR determination. n= 22 patients elected to not undergo PCI, or were withdrawn by the treating physicians.
影响因子:
39.3
作者:
Layland J;Oldroyd KG;Curzen N;Sood A;Balachandran K;Das R;Junejo S;Ahmed N;Lee MM;Shaukat A;O'Donnell A;Nam J;Briggs A;Henderson R;McConnachie A;Berry C;FAMOUS–NSTEMI investigators
通讯作者:
FAMOUS–NSTEMI investigators